์ฝ˜ํ…์ธ ๋กœ ๊ฑด๋„ˆ๋›ฐ๊ธฐ
Merck
HomeMammalian Cell CultureRPMI-1640 Media Formulation

RPMI-1640 Media Formulation

RPMI-1640 was developed by Moore et. al. at Roswell Park Memorial Institute, hence the acronym RPMI. The formulation is based on the RPMI-1630 series of media utilizing a bicarbonate buffering system and alterations in the amounts of amino acids and vitamins. RPMI-1640 medium is commonly used for suspension cultures of mammalian and primary cells, such as HeLa cells, human peripheral blood mononuclear cells (PBMCs), human normal and neoplastic leukocytes, Jukrat cells, and more. RPMI-1640, when properly supplemented, has demonstrated wide applicability for supporting growth of many types of cultured cells, including fresh human lymphocytes in the 72-hour phytohemaglutinin (PHA) stimulation assay.

RPMI-1640 Medium Composition

RPMI-1640 Medium Dutch Modification

RPMI-1640 Medium HEPES Modification

RPMI-1640 Medium Modified

RPMI-1640 Medium Auto-Modโ„ข Modified for Autoclaving

๊ณ„์†ํ•˜๋ ค๋ฉด ๋กœ๊ทธ์ธํ•˜์„ธ์š”.

๊ณ„์† ์ฝ์œผ์‹œ๋ ค๋ฉด ๋กœ๊ทธ์ธํ•˜๊ฑฐ๋‚˜ ๊ณ„์ •์„ ์ƒ์„ฑํ•˜์„ธ์š”.

๊ณ„์ •์ด ์—†์œผ์‹ญ๋‹ˆ๊นŒ?